{
  "directed": true,
  "graph": {
    "annotation_list": {},
    "annotation_pattern": {
      "Species": "^\\d+$"
    },
    "annotation_url": {
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno"
    },
    "document_metadata": {
      "authors": "Yojana Gadiya",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright Â© 2019 Fraunhofer Institute SCAI, All rights reserved.",
      "description": "",
      "licenses": "CC BY 4.0",
      "name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
      "version": "1.0.0"
    },
    "namespace_pattern": {
      "MP": "^\\d{7}$",
      "PUBCHEM": "^\\d+$"
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/chebi-names.belns",
      "CONSO": "https://raw.githubusercontent.com/pharmacome/conso/3c93a65dc48e6786fe29ae55aa36cf9a902fe8c6/export/conso-names.belns",
      "DOID": "https://raw.githubusercontent.com/pharmacome/conso/c0c576e3d3ab9b25a3982251a4ee2fd7c49e1679/external/doid-names.belns",
      "EFO": "https://raw.githubusercontent.com/pharmacome/conso/5d2c2ea6f7112421cc8089a3f021a75ab60bb373/external/efo-names.belns",
      "FB": "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/fb-names.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/conso/d9d270e11aac480542c412d4222983a5f042b8ae/external/go-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc-names.belns",
      "HGNCGENEFAMILY": "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc.genefamily-names.belns",
      "HP": "https://raw.githubusercontent.com/pharmacome/conso/d9d270e11aac480542c412d4222983a5f042b8ae/external/hp-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/conso/f02c6ad4a4791a8ed45448513b9de8c8f1b00c87/external/mesh-names.belns"
    },
    "path": "huntington/jin2010.bel",
    "pybel_version": "0.14.10"
  },
  "links": [
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neocortex": true,
          "Neostriatum": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "For example, positron emission tomography (PET) scans that utilize 18F-2- deoxyglucose (18F-2-DOG) showed a significant reduction in glucose uptake in cortex and striatum of HD patients even prior to striatal neuronal loss and pathological symptoms (Gil and Rego 2008).",
      "key": "17c3f7646899407ee496da4b53f11a3f",
      "line": 85,
      "relation": "decreases",
      "source": 60,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neocortex": true,
          "Neostriatum": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "Paradoxical increases in lactate have been observed in the cortex of symptomatic HD patients and in the striatum of presymptomatic HD patients using 1Hmagnetic resonance spectroscopy (MRS) (Jenkins et al. 1998).",
      "key": "88cfcb97ede60a5d4e0c09ca0ced59c3",
      "line": 92,
      "relation": "increases",
      "source": 60,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "In addition, functional defects have been observed. For example, deficits in succinate dehydrogenase activity, a component of complex II of ETC as well as the TCA cycle, were observed in postmortem HD brains in 1974 (Stahl and Swanson 1974).",
      "key": "cff35f7201c944fbca9ff788d6f509c6",
      "line": 102,
      "relation": "negativeCorrelation",
      "source": 60,
      "target": 24
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "In addition, functional defects have been observed. For example, deficits in succinate dehydrogenase activity, a component of complex II of ETC as well as the TCA cycle, were observed in postmortem HD brains in 1974 (Stahl and Swanson 1974).",
      "key": "44b2a1864d1e434e4a06885f90aff26b",
      "line": 103,
      "relation": "negativeCorrelation",
      "source": 60,
      "target": 26
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neostriatum": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "Reduced expression of complex II subunits has been observed in striatum of HD patients (Benchoua et al. 2006).",
      "key": "b870c203b73e2c25b8f30dcc67edf49c",
      "line": 112,
      "relation": "decreases",
      "source": 60,
      "target": 55
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Caudate Nucleus": true,
          "Putamen": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "The activities of complex III in the caudate and putamen and complex IV in the putamen are also significantly decreased in HD cases (Gil and Rego 2008).",
      "key": "dc2d294b6f593d25e86b3e26cff959c7",
      "line": 120,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 60,
      "target": 56
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Putamen": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "The activities of complex III in the caudate and putamen and complex IV in the putamen are also significantly decreased in HD cases (Gil and Rego 2008).",
      "key": "bd18d92d3beb2a2f3133e5e5a4d507d6",
      "line": 123,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 60,
      "target": 57
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Cerebral Cortex": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "Concurrent with these changes in mitochondrial morphology and function, there is a significant decrease in mitochondrial DNA in the cerebral cortex of HD patients (Horton et al. 1995).",
      "key": "a435428ca4679a182fbfa06d3312c050",
      "line": 144,
      "relation": "decreases",
      "source": 60,
      "target": 11
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Muscles": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "31P-MRS showed significantly reduced ATP production in muscle of presymptomatic and symptomatic HD patients (Lodi et al. 2000).",
      "key": "d226e354d2dccbc812ea18fc5043e645",
      "line": 151,
      "relation": "decreases",
      "source": 60,
      "target": 12
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Leukocytes": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "As in the brain, mitochondrial DNA in leukocytes from HD patients was depleted (Liu et al. 2008).",
      "key": "c8dbd028a5a04052b22f4c4cb98f0f01",
      "line": 169,
      "relation": "decreases",
      "source": 60,
      "target": 12
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Lymphoid Progenitor Cells": true,
          "Muscles": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "Other groups found out abnormal morphologies as well as decreased membrane potential in mitochondria from peripheral tissues including lymphoblasts and muscle of HD patients (Panov et al. 2002; Squitieri et al. 2006, 2010).",
      "key": "a53401370aabb6b872477ab4530c0fba",
      "line": 161,
      "relation": "increases",
      "source": 60,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "A decreased stability of muscle mitochondria against Ca2+-induced mPTP opening and an increased sensitivity of complex I-dependent respiration against Ca2+-induced inhibition have been found in R6/2 mice, leading to energetic deficits and muscle atrophy (Gizatullina et al. 2006).",
      "key": "d72f3f3656450ac86365393775f85021",
      "line": 178,
      "relation": "negativeCorrelation",
      "source": 60,
      "target": 28
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "A decreased stability of muscle mitochondria against Ca2+-induced mPTP opening and an increased sensitivity of complex I-dependent respiration against Ca2+-induced inhibition have been found in R6/2 mice, leading to energetic deficits and muscle atrophy (Gizatullina et al. 2006).",
      "key": "2cc2f4f7a14a4de45d9e4cea4d7dce99",
      "line": 179,
      "relation": "increases",
      "source": 60,
      "target": 64
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Lymphoid Progenitor Cells": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "Panov et al. (2002) showed that mitochondria isolated from lymphoblasts of HD patients have decreased Ca2+-buffering capacity and undergo mitochondrial membrane depolarization at lower Ca2+ concentrations.",
      "key": "4ddf85f01d4fa6f8ab1113d025dafd4b",
      "line": 187,
      "relation": "decreases",
      "source": 60,
      "target": 14
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Mitochondrial Membranes": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "Panov et al. (2002) showed that mitochondria isolated from lymphoblasts of HD patients have decreased Ca2+-buffering capacity and undergo mitochondrial membrane depolarization at lower Ca2+ concentrations.",
      "key": "1a4fb3bfc884bfe16d8cd9baf2c13b7a",
      "line": 190,
      "relation": "decreases",
      "source": 60,
      "target": 20
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "In addition, functional defects have been observed. For example, deficits in succinate dehydrogenase activity, a component of complex II of ETC as well as the TCA cycle, were observed in postmortem HD brains in 1974 (Stahl and Swanson 1974).",
      "key": "3664fd6b072c595ecc91456e098e91e8",
      "line": 102,
      "relation": "negativeCorrelation",
      "source": 24,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Brain": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "In addition, functional defects have been observed. For example, deficits in succinate dehydrogenase activity, a component of complex II of ETC as well as the TCA cycle, were observed in postmortem HD brains in 1974 (Stahl and Swanson 1974).",
      "key": "ae9e8f53326c95a396c9f309667196a9",
      "line": 103,
      "relation": "negativeCorrelation",
      "source": 26,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neocortex": true,
          "Neostriatum": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "The activity of aconitase, an essential enzyme in the TCA cycle, has been reported to be significantly decreased in the striatum and cerebral cortex (Tabrizi et al. 2000), and loss of the pyruvate dehydrogenase complex was observed in symptomatic patients with caudate/putamen atrophy (Butterworth et al. 1985; Sorbi et al. 1983).",
      "key": "8479e6eb94effe015cf281ef32269c89",
      "line": 134,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 67,
      "target": 41
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "The activity of aconitase, an essential enzyme in the TCA cycle, has been reported to be significantly decreased in the striatum and cerebral cortex (Tabrizi et al. 2000), and loss of the pyruvate dehydrogenase complex was observed in symptomatic patients with caudate/putamen atrophy (Butterworth et al. 1985; Sorbi et al. 1983).",
      "key": "c87e906cde4eb65e3946f3ec42e88f21",
      "line": 136,
      "relation": "negativeCorrelation",
      "source": 67,
      "target": 58
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "The activity of aconitase, an essential enzyme in the TCA cycle, has been reported to be significantly decreased in the striatum and cerebral cortex (Tabrizi et al. 2000), and loss of the pyruvate dehydrogenase complex was observed in symptomatic patients with caudate/putamen atrophy (Butterworth et al. 1985; Sorbi et al. 1983).",
      "key": "6b39b28c459d836b852a6cf312794290",
      "line": 136,
      "relation": "negativeCorrelation",
      "source": 58,
      "target": 67
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "A decreased stability of muscle mitochondria against Ca2+-induced mPTP opening and an increased sensitivity of complex I-dependent respiration against Ca2+-induced inhibition have been found in R6/2 mice, leading to energetic deficits and muscle atrophy (Gizatullina et al. 2006).",
      "key": "b7a717cfaddde70272691265e6a04106",
      "line": 178,
      "relation": "negativeCorrelation",
      "source": 28,
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neostriatum": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "Striatal neurons from Hdh150 knock-in mice exhibit increased susceptibility to Ca2+-deregulation by NMDA receptor activation than striatal neurons from wild type littermates, when pyruvate instead of glucose is used in media to emphasize Oxphos dependent bioenergetics (Oliveira et al. 2007).",
      "key": "e6621b34e0938e7047b2fa781c589bf7",
      "line": 233,
      "object": {
        "modifier": "Activity"
      },
      "relation": "association",
      "source": 14,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Mitochondrial Membranes": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "Panov et al. (2002) showed that mitochondria isolated from lymphoblasts of HD patients have decreased Ca2+-buffering capacity and undergo mitochondrial membrane depolarization at lower Ca2+ concentrations.",
      "key": "dbe0779d64b0d47acc08c7c16993c152",
      "line": 189,
      "relation": "regulates",
      "source": 3,
      "target": 20
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Mitochondria, Liver": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "A recombinant truncated mHtt directly added to isolated mouse liver mitochondria significantly decreased the Ca2+-threshold for mPTP opening, an effect that was abolished by cyclosporin A (CsA), an mPTP inhibitor.",
      "key": "6dd56bdd55e535f1158ca947cc370947",
      "line": 210,
      "relation": "regulates",
      "source": 3,
      "target": 31
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "Choo et al. (2004) showed that huntingtin was present in the mitochondrial fraction purified from human neuroblastoma cells and clonal striatal cells and associated with the outer mitochondrial membrane.",
      "key": "12675e8b5fc1f8f01db54e6c4372faa0",
      "line": 199,
      "object": {
        "location": {
          "name": "mitochondrial outer membrane",
          "namespace": "GO"
        }
      },
      "relation": "increases",
      "source": 65,
      "target": 45
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neostriatum": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "Striatal neurons from Hdh150 knock-in mice exhibit increased susceptibility to Ca2+-deregulation by NMDA receptor activation than striatal neurons from wild type littermates, when pyruvate instead of glucose is used in media to emphasize Oxphos dependent bioenergetics (Oliveira et al. 2007).",
      "key": "fe79e66ca481d80b031337ecffc7b56e",
      "line": 232,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 45,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "Moreover, mHtt enhances the activity of N-methyl D-aspartate receptors (NMDARs) harboring the NR2B subunit, resulting from increased NMDAR trafficking to the plasma membrane (Fan et al. 2007; Sun et al. 2001; Zeron et al. 2002).",
      "key": "cd7c8e5682f5853783406ef335431e8d",
      "line": 251,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "cytoplasm",
            "namespace": "GO"
          },
          "toLoc": {
            "name": "plasma membrane",
            "namespace": "GO"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 45,
      "target": 54
    },
    {
      "key": "4a3c27a5bb347dfe310a5e03115bbdf0",
      "relation": "partOf",
      "source": 45,
      "target": 34
    },
    {
      "key": "d2146815e5e1ade974270dc67d31565d",
      "relation": "partOf",
      "source": 45,
      "target": 35
    },
    {
      "key": "d4bbc5b1a0bca28ff30dcf303171a4b7",
      "relation": "partOf",
      "source": 45,
      "target": 36
    },
    {
      "key": "470a1ae048486b05ca935560ba3d84a7",
      "relation": "partOf",
      "source": 45,
      "target": 32
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "Initial studies showed that mHtt interferes with cAMP-responsive element (CRE) binding protein (CREB) mediated transcriptional processes through direct interaction with CBP (CREB-binding protein) (Steffan et al. 2000) and with TATA box-binding protein (TBP)- associated factor TAF4/ TAFII130 (Dunah et al. 2002; Shimohata et al. 2000), leading to an increase in mHtt-induced cytotoxicity (Steffan et al. 2001).",
      "key": "135792cfa37cd12d05912d57569a62c0",
      "line": 318,
      "relation": "increases",
      "source": 45,
      "target": 70
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "The expression of PGC-1Î± is repressed in both in vitro and in vivo models of HD, at least partially due to the fact that mHtt directly interferes with the CREB/TAF4 signaling pathway which is a predominant regulator of PGC-1Î± expression (Cui et al. 2006).",
      "key": "acda25f383fff166fcbba26a2f24c7f6",
      "line": 349,
      "relation": "decreases",
      "source": 45,
      "target": 72
    },
    {
      "key": "0ce6657d55cebf519ec5f8609a572687",
      "relation": "hasVariant",
      "source": 44,
      "target": 45
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Mitochondria, Liver": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "A recombinant truncated mHtt directly added to isolated mouse liver mitochondria significantly decreased the Ca2+-threshold for mPTP opening, an effect that was abolished by cyclosporin A (CsA), an mPTP inhibitor.",
      "key": "5fa95909812bc2c615e473481bb82b74",
      "line": 211,
      "relation": "decreases",
      "source": 4,
      "target": 31
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "In addition, inhibition of mPTP opening by treatment with CsA and bongkrekic acid significantly diminished NMDA-induced Ca2+ influx and mitochondrial membrane potential loss in MSNs of YAC128 mouse (Fernandes et al. 2007).",
      "key": "4113fac67281dc2fdd0b7051267401eb",
      "line": 272,
      "relation": "decreases",
      "source": 4,
      "target": 31
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Mitochondrial Membranes": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "ADP treatment attenuated the mitochondrial membrane potential defect and CsA treatment prevented the decreases in Ca2+ uptake capacity (Milakovic et al. 2006).",
      "key": "35e2e6fa88638db0762edd41464a06e1",
      "line": 220,
      "relation": "increases",
      "source": 4,
      "target": 13
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "In addition, inhibition of mPTP opening by treatment with CsA and bongkrekic acid significantly diminished NMDA-induced Ca2+ influx and mitochondrial membrane potential loss in MSNs of YAC128 mouse (Fernandes et al. 2007).",
      "key": "4795084dd83038cb928bc4725023dd5e",
      "line": 274,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 4,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "In addition, inhibition of mPTP opening by treatment with CsA and bongkrekic acid significantly diminished NMDA-induced Ca2+ influx and mitochondrial membrane potential loss in MSNs of YAC128 mouse (Fernandes et al. 2007).",
      "key": "5b6d92f31f04729db0bf19448415a936",
      "line": 277,
      "relation": "decreases",
      "source": 4,
      "target": 15
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "In addition, inhibition of mPTP opening by treatment with CsA and bongkrekic acid significantly diminished NMDA-induced Ca2+ influx and mitochondrial membrane potential loss in MSNs of YAC128 mouse (Fernandes et al. 2007).",
      "key": "b64e435a403413244533a62b4b9ad222",
      "line": 280,
      "relation": "regulates",
      "source": 4,
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Mitochondrial Membranes": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "ADP treatment attenuated the mitochondrial membrane potential defect and CsA treatment prevented the decreases in Ca2+ uptake capacity (Milakovic et al. 2006).",
      "key": "296fde34b2b21e2a1aa864bfa4b5b7d5",
      "line": 219,
      "relation": "increases",
      "source": 6,
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neostriatum": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "Striatal neurons from Hdh150 knock-in mice exhibit increased susceptibility to Ca2+-deregulation by NMDA receptor activation than striatal neurons from wild type littermates, when pyruvate instead of glucose is used in media to emphasize Oxphos dependent bioenergetics (Oliveira et al. 2007).",
      "key": "496794c010475ef808d442b4c78b0637",
      "line": 233,
      "relation": "association",
      "source": 54,
      "subject": {
        "modifier": "Activity"
      },
      "target": 14
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "Moreover, mHtt enhances the activity of N-methyl D-aspartate receptors (NMDARs) harboring the NR2B subunit, resulting from increased NMDAR trafficking to the plasma membrane (Fan et al. 2007; Sun et al. 2001; Zeron et al. 2002).",
      "key": "a08f633ba4d3d49c99b87efbf1c3fb52",
      "line": 252,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 54,
      "subject": {
        "effect": {
          "fromLoc": {
            "name": "cytoplasm",
            "namespace": "GO"
          },
          "toLoc": {
            "name": "plasma membrane",
            "namespace": "GO"
          }
        },
        "modifier": "Translocation"
      },
      "target": 54
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "Importantly, MSNs express high levels of the NR2B subunit, implying a greater sensitivity to excitotoxicity caused by NMDAR activation (Heng et al. 2009; Rigby et al. 1996).",
      "key": "c41efb5f75a1e0499d8fda3378e29b17",
      "line": 262,
      "relation": "increases",
      "source": 54,
      "subject": {
        "modifier": "Activity"
      },
      "target": 71
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "In addition, inhibition of mPTP opening by treatment with CsA and bongkrekic acid significantly diminished NMDA-induced Ca2+ influx and mitochondrial membrane potential loss in MSNs of YAC128 mouse (Fernandes et al. 2007).",
      "key": "f930fded3b169558175b9ac810ad1de9",
      "line": 276,
      "relation": "increases",
      "source": 54,
      "subject": {
        "modifier": "Activity"
      },
      "target": 15
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "mHtt directly interacts with C-terminal region of the type 1 inositol 1,4,5-trisphosphate (InsP3) receptor (InsP3R1), resulting in increased sensitivity of InsP3R1 to activation by InsP3 (Tang et al. 2003).",
      "key": "ee525aa6848d7221534b0c43db8e8065",
      "line": 243,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 34,
      "target": 46
    },
    {
      "key": "5e2ef41c61638c3d53ec8aa9df0b64b4",
      "relation": "partOf",
      "source": 47,
      "target": 34
    },
    {
      "key": "8b6c6f7d187a5b937ad77647ac07774f",
      "relation": "hasVariant",
      "source": 46,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "mHtt directly interacts with C-terminal region of the type 1 inositol 1,4,5-trisphosphate (InsP3) receptor (InsP3R1), resulting in increased sensitivity of InsP3R1 to activation by InsP3 (Tang et al. 2003).",
      "key": "d46de8a558f3ffbdd0e6861d84cc36c3",
      "line": 244,
      "relation": "increases",
      "source": 46,
      "subject": {
        "modifier": "Activity"
      },
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "Importantly, MSNs express high levels of the NR2B subunit, implying a greater sensitivity to excitotoxicity caused by NMDAR activation (Heng et al. 2009; Rigby et al. 1996).",
      "key": "a35efee618f897825e1472344d6cf1a8",
      "line": 263,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 43,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "Importantly, MSNs express high levels of the NR2B subunit, implying a greater sensitivity to excitotoxicity caused by NMDAR activation (Heng et al. 2009; Rigby et al. 1996).",
      "key": "859cc82e33ea2681a7bfe2f4c1c4520a",
      "line": 264,
      "relation": "increases",
      "source": 43,
      "target": 71
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "In addition, inhibition of mPTP opening by treatment with CsA and bongkrekic acid significantly diminished NMDA-induced Ca2+ influx and mitochondrial membrane potential loss in MSNs of YAC128 mouse (Fernandes et al. 2007).",
      "key": "732698a548d519c22e065c0f5fd63d1c",
      "line": 273,
      "relation": "decreases",
      "source": 2,
      "target": 31
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "In addition, inhibition of mPTP opening by treatment with CsA and bongkrekic acid significantly diminished NMDA-induced Ca2+ influx and mitochondrial membrane potential loss in MSNs of YAC128 mouse (Fernandes et al. 2007).",
      "key": "0f6b400dae9c9a949c043c3b918066cf",
      "line": 275,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 2,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "In addition, inhibition of mPTP opening by treatment with CsA and bongkrekic acid significantly diminished NMDA-induced Ca2+ influx and mitochondrial membrane potential loss in MSNs of YAC128 mouse (Fernandes et al. 2007).",
      "key": "a86c81b3793b5a52ac94d763eae7cc6e",
      "line": 278,
      "relation": "decreases",
      "source": 2,
      "target": 15
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "In addition, inhibition of mPTP opening by treatment with CsA and bongkrekic acid significantly diminished NMDA-induced Ca2+ influx and mitochondrial membrane potential loss in MSNs of YAC128 mouse (Fernandes et al. 2007).",
      "key": "c34e4d275c4215e1592247e77e2d196e",
      "line": 281,
      "relation": "regulates",
      "source": 2,
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "Similarly, Htt is likely to have an effect on the function of the voltage-gated Ca2+ channels (VGCCs), because Htt associates with the synaptic protein interaction (synprint) region of N-type VGCC (Swayne et al. 2005) and the Î±2/Î´ auxiliary subunit of VGCC (Kaltenbach et al. 2007), and MSNs from R6/2 mice at 3â6 weeks of age show increases in voltage-gated Ca2+ conductances (Cepeda et al. 2007).",
      "key": "74509e64649a58f12df1672804ff1e91",
      "line": 291,
      "relation": "increases",
      "source": 35,
      "target": 25
    },
    {
      "key": "c76af306411802676517e0199547a00c",
      "relation": "partOf",
      "source": 52,
      "target": 35
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "Similarly, Htt is likely to have an effect on the function of the voltage-gated Ca2+ channels (VGCCs), because Htt associates with the synaptic protein interaction (synprint) region of N-type VGCC (Swayne et al. 2005) and the Î±2/Î´ auxiliary subunit of VGCC (Kaltenbach et al. 2007), and MSNs from R6/2 mice at 3â6 weeks of age show increases in voltage-gated Ca2+ conductances (Cepeda et al. 2007).",
      "key": "45ede23bbd79a27285045826314a718e",
      "line": 292,
      "relation": "increases",
      "source": 36,
      "target": 25
    },
    {
      "key": "1fc399183d376e3a7ed65517e3bb2d7c",
      "relation": "partOf",
      "source": 53,
      "target": 36
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Photoreceptor Cells": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        },
        "Species": {
          "7227": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "Photoreceptor neurodegeneration in an HD fly model expressing a full length of mHtt with a polyglutamine stretch of 128 was rescued by removing one copy of Dmca1D (a Ltype VGCC pore subunit of Drosophila) (Romero et al. 2008).",
      "key": "ffca116f068b6e923b7cf3c21d89f7e8",
      "line": 303,
      "relation": "increases",
      "source": 40,
      "target": 69
    },
    {
      "key": "d31f603a1d0bd6c4037904729531f223",
      "relation": "hasVariant",
      "source": 39,
      "target": 40
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Photoreceptor Cells": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        },
        "Species": {
          "7227": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "Photoreceptor neurodegeneration in an HD fly model expressing a full length of mHtt with a polyglutamine stretch of 128 was rescued by removing one copy of Dmca1D (a Ltype VGCC pore subunit of Drosophila) (Romero et al. 2008).",
      "key": "3218bf53d4dd6657dcc1937fe94c354e",
      "line": 304,
      "relation": "decreases",
      "source": 38,
      "target": 69
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "Initial studies showed that mHtt interferes with cAMP-responsive element (CRE) binding protein (CREB) mediated transcriptional processes through direct interaction with CBP (CREB-binding protein) (Steffan et al. 2000) and with TATA box-binding protein (TBP)- associated factor TAF4/ TAFII130 (Dunah et al. 2002; Shimohata et al. 2000), leading to an increase in mHtt-induced cytotoxicity (Steffan et al. 2001).",
      "key": "c8e68fe92c992a81324343c33a2b0cf8",
      "line": 315,
      "object": {
        "effect": {
          "name": "tscript",
          "namespace": "bel"
        },
        "modifier": "Activity"
      },
      "relation": "negativeCorrelation",
      "source": 32,
      "target": 42
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "Initial studies showed that mHtt interferes with cAMP-responsive element (CRE) binding protein (CREB) mediated transcriptional processes through direct interaction with CBP (CREB-binding protein) (Steffan et al. 2000) and with TATA box-binding protein (TBP)- associated factor TAF4/ TAFII130 (Dunah et al. 2002; Shimohata et al. 2000), leading to an increase in mHtt-induced cytotoxicity (Steffan et al. 2001).",
      "key": "41767e95282d6e2a4aea7b26d9d5cb7b",
      "line": 316,
      "relation": "increases",
      "source": 32,
      "target": 70
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "Initial studies showed that mHtt interferes with cAMP-responsive element (CRE) binding protein (CREB) mediated transcriptional processes through direct interaction with CBP (CREB-binding protein) (Steffan et al. 2000) and with TATA box-binding protein (TBP)- associated factor TAF4/ TAFII130 (Dunah et al. 2002; Shimohata et al. 2000), leading to an increase in mHtt-induced cytotoxicity (Steffan et al. 2001).",
      "key": "8744824bee2d154bb3142c586e508d38",
      "line": 317,
      "relation": "increases",
      "source": 32,
      "target": 45
    },
    {
      "key": "cd9c4ee07935f2393641dd3cc9e3a87d",
      "relation": "partOf",
      "source": 42,
      "target": 32
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "Initial studies showed that mHtt interferes with cAMP-responsive element (CRE) binding protein (CREB) mediated transcriptional processes through direct interaction with CBP (CREB-binding protein) (Steffan et al. 2000) and with TATA box-binding protein (TBP)- associated factor TAF4/ TAFII130 (Dunah et al. 2002; Shimohata et al. 2000), leading to an increase in mHtt-induced cytotoxicity (Steffan et al. 2001).",
      "key": "65748a6224a501758b2b3131bccc61bb",
      "line": 315,
      "relation": "negativeCorrelation",
      "source": 42,
      "subject": {
        "effect": {
          "name": "tscript",
          "namespace": "bel"
        },
        "modifier": "Activity"
      },
      "target": 32
    },
    {
      "key": "046ab2f69c1bd835212e0efb7ed6ed08",
      "relation": "partOf",
      "source": 42,
      "target": 33
    },
    {
      "key": "60f99d22d474630f8754cd6a35df2393",
      "relation": "partOf",
      "source": 51,
      "target": 32
    },
    {
      "key": "10242276436ea68ba3c7a5bc09d461be",
      "relation": "partOf",
      "source": 51,
      "target": 33
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "The peroxisome proliferator-activated receptor Î³ (PPARÎ³) coactivator-1Î± (PGC-1Î±) is an orchestrator of mitochondrial function via integration of signals that regulate mitochondrial biogenesis and respiration, detoxification of ROS, energy metabolism, and thermogenesis (Houten and Auwerx 2004).",
      "key": "b2bbbf7e257dbe1f28c112201bd6ff6b",
      "line": 326,
      "relation": "regulates",
      "source": 50,
      "target": 29
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "The peroxisome proliferator-activated receptor Î³ (PPARÎ³) coactivator-1Î± (PGC-1Î±) is an orchestrator of mitochondrial function via integration of signals that regulate mitochondrial biogenesis and respiration, detoxification of ROS, energy metabolism, and thermogenesis (Houten and Auwerx 2004).",
      "key": "7ff3a35df6df39b790767820d2150881",
      "line": 327,
      "relation": "regulates",
      "source": 50,
      "target": 21
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "The peroxisome proliferator-activated receptor Î³ (PPARÎ³) coactivator-1Î± (PGC-1Î±) is an orchestrator of mitochondrial function via integration of signals that regulate mitochondrial biogenesis and respiration, detoxification of ROS, energy metabolism, and thermogenesis (Houten and Auwerx 2004).",
      "key": "db60a9b269472f9071ef840273b8b8ed",
      "line": 328,
      "relation": "regulates",
      "source": 50,
      "target": 16
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "The peroxisome proliferator-activated receptor Î³ (PPARÎ³) coactivator-1Î± (PGC-1Î±) is an orchestrator of mitochondrial function via integration of signals that regulate mitochondrial biogenesis and respiration, detoxification of ROS, energy metabolism, and thermogenesis (Houten and Auwerx 2004).",
      "key": "77e1aa1c11677acee3c605d66c52251b",
      "line": 329,
      "relation": "increases",
      "source": 50,
      "target": 5
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "The peroxisome proliferator-activated receptor Î³ (PPARÎ³) coactivator-1Î± (PGC-1Î±) is an orchestrator of mitochondrial function via integration of signals that regulate mitochondrial biogenesis and respiration, detoxification of ROS, energy metabolism, and thermogenesis (Houten and Auwerx 2004).",
      "key": "51eb28944c194b7f87d9b7811f3d42e5",
      "line": 330,
      "relation": "regulates",
      "source": 50,
      "target": 27
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "The peroxisome proliferator-activated receptor Î³ (PPARÎ³) coactivator-1Î± (PGC-1Î±) is an orchestrator of mitochondrial function via integration of signals that regulate mitochondrial biogenesis and respiration, detoxification of ROS, energy metabolism, and thermogenesis (Houten and Auwerx 2004).",
      "key": "ef6f9b64629d310c463af5ea3eef237a",
      "line": 331,
      "relation": "regulates",
      "source": 50,
      "target": 28
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "The peroxisome proliferator-activated receptor Î³ (PPARÎ³) coactivator-1Î± (PGC-1Î±) is an orchestrator of mitochondrial function via integration of signals that regulate mitochondrial biogenesis and respiration, detoxification of ROS, energy metabolism, and thermogenesis (Houten and Auwerx 2004).",
      "key": "a9576191fbe4bea7fbdf2225f2817d7c",
      "line": 332,
      "relation": "regulates",
      "source": 50,
      "target": 30
    },
    {
      "key": "7cf0a57710d2b9141db1ca4e286182b7",
      "relation": "partOf",
      "source": 50,
      "target": 37
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "PGC-1Î± interacts with a number of transcription factors including PPARÎ³ of the PPAR family, which regulates adipogenesis and lipid metabolism, and the nuclear respiratory factor-1/2 (NRF-1/2) which play a pivotal role in mitochondrial respiration.",
      "key": "b3c80035a963f6e94bbc8f423981c364",
      "line": 340,
      "relation": "regulates",
      "source": 37,
      "target": 16
    },
    {
      "key": "f29c1e6e10a8e6d0a2b49f50fac73b60",
      "relation": "partOf",
      "source": 48,
      "target": 37
    },
    {
      "key": "2d6725b1c5e544359b4a741b5ad7242b",
      "relation": "partOf",
      "source": 49,
      "target": 37
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "PGC-1Î± interacts with a number of transcription factors including PPARÎ³ of the PPAR family, which regulates adipogenesis and lipid metabolism, and the nuclear respiratory factor-1/2 (NRF-1/2) which play a pivotal role in mitochondrial respiration.",
      "key": "da397c7664a96ea1ddfae1115173fd07",
      "line": 341,
      "relation": "regulates",
      "source": 49,
      "target": 18
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "PGC-1Î± interacts with a number of transcription factors including PPARÎ³ of the PPAR family, which regulates adipogenesis and lipid metabolism, and the nuclear respiratory factor-1/2 (NRF-1/2) which play a pivotal role in mitochondrial respiration.",
      "key": "6e22a974877739cff722356c9518492d",
      "line": 342,
      "relation": "regulates",
      "source": 49,
      "target": 19
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "The expression of PGC-1Î± is repressed in both in vitro and in vivo models of HD, at least partially due to the fact that mHtt directly interferes with the CREB/TAF4 signaling pathway which is a predominant regulator of PGC-1Î± expression (Cui et al. 2006).",
      "key": "c9e48852e85b557fd9f5705b7dcd10a1",
      "line": 350,
      "relation": "regulates",
      "source": 33,
      "target": 72
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "The reduced level of cAMP in HD mice and HD patients likely contributes to the significant reduction in CREB activation (Gines et al. 2003).",
      "key": "8ce61a5af8fd80f2f233544d5e90340a",
      "line": 357,
      "object": {
        "effect": {
          "name": "tscript",
          "namespace": "bel"
        },
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 1,
      "target": 42
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "Recent studies demonstrate that TZDs show protective effects in models of Alzheimerâs disease (Heneka et al. 2005; Landreth 2006), Parkinsonâs disease (Breidert et al. 2002), amyotrophic lateral sclerosis (Kiaei et al. 2005), stroke (Luo et al. 2006), and multiple sclerosis (Niino et al. 2001).",
      "key": "6148fd3de3ca497b139399f6d0c351a6",
      "line": 368,
      "relation": "decreases",
      "source": 10,
      "target": 59
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "Recent studies demonstrate that TZDs show protective effects in models of Alzheimerâs disease (Heneka et al. 2005; Landreth 2006), Parkinsonâs disease (Breidert et al. 2002), amyotrophic lateral sclerosis (Kiaei et al. 2005), stroke (Luo et al. 2006), and multiple sclerosis (Niino et al. 2001).",
      "key": "cf1e2767ef40d431f831446d8eb71f19",
      "line": 369,
      "relation": "decreases",
      "source": 10,
      "target": 61
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "Recent studies demonstrate that TZDs show protective effects in models of Alzheimerâs disease (Heneka et al. 2005; Landreth 2006), Parkinsonâs disease (Breidert et al. 2002), amyotrophic lateral sclerosis (Kiaei et al. 2005), stroke (Luo et al. 2006), and multiple sclerosis (Niino et al. 2001).",
      "key": "a63af964b469c2bcd437661361d02fac",
      "line": 370,
      "relation": "decreases",
      "source": 10,
      "target": 62
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "Recent studies demonstrate that TZDs show protective effects in models of Alzheimerâs disease (Heneka et al. 2005; Landreth 2006), Parkinsonâs disease (Breidert et al. 2002), amyotrophic lateral sclerosis (Kiaei et al. 2005), stroke (Luo et al. 2006), and multiple sclerosis (Niino et al. 2001).",
      "key": "f6a277ab094867dffb7133d8cd959491",
      "line": 371,
      "relation": "decreases",
      "source": 10,
      "target": 66
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "Recent studies demonstrate that TZDs show protective effects in models of Alzheimerâs disease (Heneka et al. 2005; Landreth 2006), Parkinsonâs disease (Breidert et al. 2002), amyotrophic lateral sclerosis (Kiaei et al. 2005), stroke (Luo et al. 2006), and multiple sclerosis (Niino et al. 2001).",
      "key": "cb4260f2ce909c5e6977cc404ac32e48",
      "line": 372,
      "relation": "decreases",
      "source": 10,
      "target": 63
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "More importantly, we found out that STHdhQ111/Q111 cells exhibit significant decreases in PPARÎ³ activity, that thapsigargin induced a decrease in mitochondrial membrane potential and an increase in ROS production only in STHdhQ111/Q111 cells, and that PPARÎ³ activation by rosiglitazone treatment protected STHdhQ111/Q111 cells from thapsigargin-induced mitochondrial membrane potential loss and ROS production (Quintanilla et al. 2008).",
      "key": "0ec6046189b08fbc9a9a90bad9c68436",
      "line": 383,
      "relation": "decreases",
      "source": 9,
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "More importantly, we found out that STHdhQ111/Q111 cells exhibit significant decreases in PPARÎ³ activity, that thapsigargin induced a decrease in mitochondrial membrane potential and an increase in ROS production only in STHdhQ111/Q111 cells, and that PPARÎ³ activation by rosiglitazone treatment protected STHdhQ111/Q111 cells from thapsigargin-induced mitochondrial membrane potential loss and ROS production (Quintanilla et al. 2008).",
      "key": "fc427f546547bdc2f0d411fc2eaa0f51",
      "line": 384,
      "relation": "increases",
      "source": 9,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "More importantly, we found out that STHdhQ111/Q111 cells exhibit significant decreases in PPARÎ³ activity, that thapsigargin induced a decrease in mitochondrial membrane potential and an increase in ROS production only in STHdhQ111/Q111 cells, and that PPARÎ³ activation by rosiglitazone treatment protected STHdhQ111/Q111 cells from thapsigargin-induced mitochondrial membrane potential loss and ROS production (Quintanilla et al. 2008).",
      "key": "a6ee106c0f4015c8af8ba9d061f333b6",
      "line": 385,
      "relation": "increases",
      "source": 8,
      "target": 49
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "More importantly, we found out that STHdhQ111/Q111 cells exhibit significant decreases in PPARÎ³ activity, that thapsigargin induced a decrease in mitochondrial membrane potential and an increase in ROS production only in STHdhQ111/Q111 cells, and that PPARÎ³ activation by rosiglitazone treatment protected STHdhQ111/Q111 cells from thapsigargin-induced mitochondrial membrane potential loss and ROS production (Quintanilla et al. 2008).",
      "key": "85a983ac28c11501bda95cb558a4c6e6",
      "line": 386,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 8,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "More importantly, we found out that STHdhQ111/Q111 cells exhibit significant decreases in PPARÎ³ activity, that thapsigargin induced a decrease in mitochondrial membrane potential and an increase in ROS production only in STHdhQ111/Q111 cells, and that PPARÎ³ activation by rosiglitazone treatment protected STHdhQ111/Q111 cells from thapsigargin-induced mitochondrial membrane potential loss and ROS production (Quintanilla et al. 2008).",
      "key": "b43e4a3b3f4ae6b341cc5d438e73aee7",
      "line": 387,
      "relation": "increases",
      "source": 8,
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Huntington Disease": true
        }
      },
      "citation": {
        "authors": [
          "Jin YN",
          "Johnson GV"
        ],
        "date": "2010-06-01",
        "db": "PubMed",
        "db_id": "20556492",
        "db_name": "The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease.",
        "first": "Jin YN",
        "journal": "Journal of bioenergetics and biomembranes",
        "last": "Johnson GV",
        "pages": "199-205",
        "volume": "42"
      },
      "evidence": "More importantly, we found out that STHdhQ111/Q111 cells exhibit significant decreases in PPARÎ³ activity, that thapsigargin induced a decrease in mitochondrial membrane potential and an increase in ROS production only in STHdhQ111/Q111 cells, and that PPARÎ³ activation by rosiglitazone treatment protected STHdhQ111/Q111 cells from thapsigargin-induced mitochondrial membrane potential loss and ROS production (Quintanilla et al. 2008).",
      "key": "fd4fe780cda91d8c1f05e00b5dc549a3",
      "line": 388,
      "relation": "decreases",
      "source": 8,
      "target": 68
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:\"1D-myo-inositol 1,4,5-trisphosphate\")",
      "concept": {
        "name": "1D-myo-inositol 1,4,5-trisphosphate",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "5458ed217affb5261b64e05f34828994"
    },
    {
      "bel": "a(CHEBI:\"3',5'-cyclic AMP\")",
      "concept": {
        "name": "3',5'-cyclic AMP",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "4cdf734bd40326dd8c20c8efe65e611f"
    },
    {
      "bel": "a(CHEBI:\"bongkrekic acid\")",
      "concept": {
        "name": "bongkrekic acid",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "42451ad1f45e1eb6008f53f2a9051926"
    },
    {
      "bel": "a(CHEBI:\"calcium(2+)\")",
      "concept": {
        "name": "calcium(2+)",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "94df77a2db8d9014b42535235da90e5d"
    },
    {
      "bel": "a(CHEBI:\"cyclosporin A\")",
      "concept": {
        "name": "cyclosporin A",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "cf700e1a91a823baf238554fae8c8461"
    },
    {
      "bel": "a(CHEBI:\"reactive oxygen species\")",
      "concept": {
        "name": "reactive oxygen species",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "39a67bec2ea8cb7a2bec39cf66e565ba"
    },
    {
      "bel": "a(CHEBI:ADP)",
      "concept": {
        "name": "ADP",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "1fd3a946ceefb4e6928ddd6a81a814b1"
    },
    {
      "bel": "a(CHEBI:lactate)",
      "concept": {
        "name": "lactate",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "655bc42fa8b4793117d7e8f4f9673c88"
    },
    {
      "bel": "a(CHEBI:rosiglitazone)",
      "concept": {
        "name": "rosiglitazone",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "f12e54218d48ea9a2e49befce5b12ee6"
    },
    {
      "bel": "a(CHEBI:thapsigargin)",
      "concept": {
        "name": "thapsigargin",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "b818dce734618f56caebf0d4267a0ee4"
    },
    {
      "bel": "a(CHEBI:thiazolidinediones)",
      "concept": {
        "name": "thiazolidinediones",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "1a224b6887ce14ed316c4214033196e0"
    },
    {
      "bel": "a(EFO:\"mitochondrial DNA\")",
      "concept": {
        "name": "mitochondrial DNA",
        "namespace": "EFO"
      },
      "function": "Abundance",
      "id": "7337a187096cd1aabc0d982dcfe3151e"
    },
    {
      "bel": "bp(GO:\"ATP biosynthetic process\")",
      "concept": {
        "name": "ATP biosynthetic process",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "96df6f1d8c5cfa09f5e6594c902772ae"
    },
    {
      "bel": "bp(GO:\"calcium import into the mitochondrion\")",
      "concept": {
        "name": "calcium import into the mitochondrion",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "b5955501396b0551ac682c5ae4eecd97"
    },
    {
      "bel": "bp(GO:\"calcium ion homeostasis\")",
      "concept": {
        "name": "calcium ion homeostasis",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "ea7019b6cc23bcd5562985b4d9fce461"
    },
    {
      "bel": "bp(GO:\"calcium ion import\")",
      "concept": {
        "name": "calcium ion import",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "590d29036363f4ebfd72792a4934582a"
    },
    {
      "bel": "bp(GO:\"cellular respiration\")",
      "concept": {
        "name": "cellular respiration",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "ced509226a10b89fb0f158c6a90c60c2"
    },
    {
      "bel": "bp(GO:\"glucose import\")",
      "concept": {
        "name": "glucose import",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "f57bac670efe08d9a46dfe9b4e490b74"
    },
    {
      "bel": "bp(GO:\"lipid biosynthetic process\")",
      "concept": {
        "name": "lipid biosynthetic process",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "440d5de4a31e1d7f176e03e475ed64b9"
    },
    {
      "bel": "bp(GO:\"lipid metabolic process\")",
      "concept": {
        "name": "lipid metabolic process",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "14433fae5fad1c2e58790171e548d3b2"
    },
    {
      "bel": "bp(GO:\"membrane depolarization\")",
      "concept": {
        "name": "membrane depolarization",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "aae614e2b00120b9a1dc849720fbd3cd"
    },
    {
      "bel": "bp(GO:\"mitochondrion organization\")",
      "concept": {
        "name": "mitochondrion organization",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "8d88a8bdfbb3b7cab315ed7796ad9990"
    },
    {
      "bel": "bp(GO:\"negative regulation of mitochondrial membrane potential\")",
      "concept": {
        "name": "negative regulation of mitochondrial membrane potential",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "455798ca343667ce69f80862aad46511"
    },
    {
      "bel": "bp(GO:\"regulation of membrane potential\")",
      "concept": {
        "name": "regulation of membrane potential",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "3d5d07ba5188bc4298f9c140be20c697"
    },
    {
      "bel": "bp(GO:\"regulation of succinate dehydrogenase activity\")",
      "concept": {
        "name": "regulation of succinate dehydrogenase activity",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "98bf5890c4a0305026d0b56e8c1b9fd9"
    },
    {
      "bel": "bp(GO:\"regulation of voltage-gated calcium channel activity\")",
      "concept": {
        "name": "regulation of voltage-gated calcium channel activity",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "b66e1f9e41814829263510adf5c3e74b"
    },
    {
      "bel": "bp(GO:\"tricarboxylic acid cycle\")",
      "concept": {
        "name": "tricarboxylic acid cycle",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "900e01cbfba00d637b8b5d2e19bb4408"
    },
    {
      "bel": "bp(GO:detoxification)",
      "concept": {
        "name": "detoxification",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "16ce616141b84bb6ac5b69b60517d66f"
    },
    {
      "bel": "bp(MESH:\"Energy Metabolism\")",
      "concept": {
        "name": "Energy Metabolism",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "5aaa959e5040d4765b684841ad0942e1"
    },
    {
      "bel": "bp(MESH:\"Mitochondrial Dynamics\")",
      "concept": {
        "name": "Mitochondrial Dynamics",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "be2818305239f205cee8cb918d076a91"
    },
    {
      "bel": "bp(MESH:Thermogenesis)",
      "concept": {
        "name": "Thermogenesis",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "44604d98d27dd74ce1dcb9204bf0a236"
    },
    {
      "bel": "complex(GO:\"mitochondrial permeability transition pore complex\")",
      "concept": {
        "name": "mitochondrial permeability transition pore complex",
        "namespace": "GO"
      },
      "function": "Complex",
      "id": "dc78c0d61a9546d9543aab781e40bb17"
    },
    {
      "bel": "complex(p(HGNC:CREBBP), p(HGNC:HTT, pmod(CONSO:\"CAG repeats\")), p(HGNC:TAF4))",
      "function": "Complex",
      "id": "4ff2991042decc28fe9874c48e308a24",
      "members": [
        {
          "bel": "p(HGNC:CREBBP)",
          "concept": {
            "name": "CREBBP",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "46148e81658994544d74b5db695e5cd8"
        },
        {
          "bel": "p(HGNC:HTT, pmod(CONSO:\"CAG repeats\"))",
          "concept": {
            "name": "HTT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "5878ef11015a6336bfafc7255b6f926f",
          "variants": [
            {
              "concept": {
                "name": "CAG repeats",
                "namespace": "CONSO"
              },
              "kind": "pmod"
            }
          ]
        },
        {
          "bel": "p(HGNC:TAF4)",
          "concept": {
            "name": "TAF4",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "e227a12a223159ea7569fe2f7ce577ba"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:CREBBP), p(HGNC:TAF4))",
      "function": "Complex",
      "id": "6d56e80be1a1bced07382bee0ff4d9e9",
      "members": [
        {
          "bel": "p(HGNC:CREBBP)",
          "concept": {
            "name": "CREBBP",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "46148e81658994544d74b5db695e5cd8"
        },
        {
          "bel": "p(HGNC:TAF4)",
          "concept": {
            "name": "TAF4",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "e227a12a223159ea7569fe2f7ce577ba"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:HTT, pmod(CONSO:\"CAG repeats\")), p(HGNC:ITPR1, frag(\"?\")))",
      "function": "Complex",
      "id": "40dc5d1e439ae25bd003d5f27fb2246b",
      "members": [
        {
          "bel": "p(HGNC:HTT, pmod(CONSO:\"CAG repeats\"))",
          "concept": {
            "name": "HTT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "5878ef11015a6336bfafc7255b6f926f",
          "variants": [
            {
              "concept": {
                "name": "CAG repeats",
                "namespace": "CONSO"
              },
              "kind": "pmod"
            }
          ]
        },
        {
          "bel": "p(HGNC:ITPR1, frag(\"?\"))",
          "concept": {
            "name": "ITPR1",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "916c73a0d528cfe16412ce8f96113375",
          "variants": [
            {
              "kind": "frag",
              "missing": "?"
            }
          ]
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:HTT, pmod(CONSO:\"CAG repeats\")), p(HGNCGENEFAMILY:\"Calcium voltage-gated channel alpha1 subunits\"))",
      "function": "Complex",
      "id": "79f405dac1967636d5d81ed77101cb41",
      "members": [
        {
          "bel": "p(HGNC:HTT, pmod(CONSO:\"CAG repeats\"))",
          "concept": {
            "name": "HTT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "5878ef11015a6336bfafc7255b6f926f",
          "variants": [
            {
              "concept": {
                "name": "CAG repeats",
                "namespace": "CONSO"
              },
              "kind": "pmod"
            }
          ]
        },
        {
          "bel": "p(HGNCGENEFAMILY:\"Calcium voltage-gated channel alpha1 subunits\")",
          "concept": {
            "name": "Calcium voltage-gated channel alpha1 subunits",
            "namespace": "HGNCGENEFAMILY"
          },
          "function": "Protein",
          "id": "e7e4919dc1aa0af21ab28946d08ebc72"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:HTT, pmod(CONSO:\"CAG repeats\")), p(HGNCGENEFAMILY:\"Calcium voltage-gated channel auxiliary alpha2delta subunits\"))",
      "function": "Complex",
      "id": "d82f59a22f65c1df596fa610f3ea19d4",
      "members": [
        {
          "bel": "p(HGNC:HTT, pmod(CONSO:\"CAG repeats\"))",
          "concept": {
            "name": "HTT",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "5878ef11015a6336bfafc7255b6f926f",
          "variants": [
            {
              "concept": {
                "name": "CAG repeats",
                "namespace": "CONSO"
              },
              "kind": "pmod"
            }
          ]
        },
        {
          "bel": "p(HGNCGENEFAMILY:\"Calcium voltage-gated channel auxiliary alpha2delta subunits\")",
          "concept": {
            "name": "Calcium voltage-gated channel auxiliary alpha2delta subunits",
            "namespace": "HGNCGENEFAMILY"
          },
          "function": "Protein",
          "id": "5df174dbd445d636f81ccd7402b9cc63"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:NRF1), p(HGNC:PPARG), p(HGNC:PPARGC1A))",
      "function": "Complex",
      "id": "ef2ba6057c0459ea5f1f94110a0c327e",
      "members": [
        {
          "bel": "p(HGNC:NRF1)",
          "concept": {
            "name": "NRF1",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "a148d341c22cdd82d8ebcf59bac2faaa"
        },
        {
          "bel": "p(HGNC:PPARG)",
          "concept": {
            "name": "PPARG",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "3c576f271f63bfbdadb98704c5b62fff"
        },
        {
          "bel": "p(HGNC:PPARGC1A)",
          "concept": {
            "name": "PPARGC1A",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "7c753b05cfed767765b0cad6e032d2f2"
        }
      ]
    },
    {
      "bel": "p(FB:\"Ca-alpha1D\")",
      "concept": {
        "name": "Ca-alpha1D",
        "namespace": "FB"
      },
      "function": "Protein",
      "id": "9fad4f6fe07badd3c7fde3175962ff15"
    },
    {
      "bel": "p(FB:htt)",
      "concept": {
        "name": "htt",
        "namespace": "FB"
      },
      "function": "Protein",
      "id": "91213d337908791f106bedf1cda6508d"
    },
    {
      "bel": "p(FB:htt, pmod(CONSO:\"CAG repeats\"))",
      "concept": {
        "name": "htt",
        "namespace": "FB"
      },
      "function": "Protein",
      "id": "d3f0f37bdd609279c8f1ad176f028074",
      "variants": [
        {
          "concept": {
            "name": "CAG repeats",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:ACO2)",
      "concept": {
        "name": "ACO2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "3df4867cf5b627b89efde73ddc8df024"
    },
    {
      "bel": "p(HGNC:CREBBP)",
      "concept": {
        "name": "CREBBP",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "46148e81658994544d74b5db695e5cd8"
    },
    {
      "bel": "p(HGNC:GRIN2B)",
      "concept": {
        "name": "GRIN2B",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "8d77980144db7590b75dcb2c4f2a9827"
    },
    {
      "bel": "p(HGNC:HTT)",
      "concept": {
        "name": "HTT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "b06bc161685303d07e7b94f740920bb7"
    },
    {
      "bel": "p(HGNC:HTT, pmod(CONSO:\"CAG repeats\"))",
      "concept": {
        "name": "HTT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "5878ef11015a6336bfafc7255b6f926f",
      "variants": [
        {
          "concept": {
            "name": "CAG repeats",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:ITPR1)",
      "concept": {
        "name": "ITPR1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "db14c687e5fc085a24d108747dc40a49"
    },
    {
      "bel": "p(HGNC:ITPR1, frag(\"?\"))",
      "concept": {
        "name": "ITPR1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "916c73a0d528cfe16412ce8f96113375",
      "variants": [
        {
          "kind": "frag",
          "missing": "?"
        }
      ]
    },
    {
      "bel": "p(HGNC:NRF1)",
      "concept": {
        "name": "NRF1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "a148d341c22cdd82d8ebcf59bac2faaa"
    },
    {
      "bel": "p(HGNC:PPARG)",
      "concept": {
        "name": "PPARG",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "3c576f271f63bfbdadb98704c5b62fff"
    },
    {
      "bel": "p(HGNC:PPARGC1A)",
      "concept": {
        "name": "PPARGC1A",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "7c753b05cfed767765b0cad6e032d2f2"
    },
    {
      "bel": "p(HGNC:TAF4)",
      "concept": {
        "name": "TAF4",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "e227a12a223159ea7569fe2f7ce577ba"
    },
    {
      "bel": "p(HGNCGENEFAMILY:\"Calcium voltage-gated channel alpha1 subunits\")",
      "concept": {
        "name": "Calcium voltage-gated channel alpha1 subunits",
        "namespace": "HGNCGENEFAMILY"
      },
      "function": "Protein",
      "id": "e7e4919dc1aa0af21ab28946d08ebc72"
    },
    {
      "bel": "p(HGNCGENEFAMILY:\"Calcium voltage-gated channel auxiliary alpha2delta subunits\")",
      "concept": {
        "name": "Calcium voltage-gated channel auxiliary alpha2delta subunits",
        "namespace": "HGNCGENEFAMILY"
      },
      "function": "Protein",
      "id": "5df174dbd445d636f81ccd7402b9cc63"
    },
    {
      "bel": "p(HGNCGENEFAMILY:\"Glutamate ionotropic receptor NMDA type subunits\")",
      "concept": {
        "name": "Glutamate ionotropic receptor NMDA type subunits",
        "namespace": "HGNCGENEFAMILY"
      },
      "function": "Protein",
      "id": "b7afccdb6102ed56132b102ce2e5f6e6"
    },
    {
      "bel": "p(HGNCGENEFAMILY:\"Mitochondrial complex II: succinate dehydrogenase subunits\")",
      "concept": {
        "name": "Mitochondrial complex II: succinate dehydrogenase subunits",
        "namespace": "HGNCGENEFAMILY"
      },
      "function": "Protein",
      "id": "1789beea27ca09f7c5d1c6115c334434"
    },
    {
      "bel": "p(HGNCGENEFAMILY:\"Mitochondrial complex III: ubiquinol-cytochrome c reductase complex subunits\")",
      "concept": {
        "name": "Mitochondrial complex III: ubiquinol-cytochrome c reductase complex subunits",
        "namespace": "HGNCGENEFAMILY"
      },
      "function": "Protein",
      "id": "3bf260e6736f535babd010f873e3bc7a"
    },
    {
      "bel": "p(HGNCGENEFAMILY:\"Mitochondrial complex IV: cytochrome c oxidase subunits\")",
      "concept": {
        "name": "Mitochondrial complex IV: cytochrome c oxidase subunits",
        "namespace": "HGNCGENEFAMILY"
      },
      "function": "Protein",
      "id": "805a1945374ceb0d8a8e349322a726cb"
    },
    {
      "bel": "p(HGNCGENEFAMILY:\"Pyruvate dehydrogenase complex\")",
      "concept": {
        "name": "Pyruvate dehydrogenase complex",
        "namespace": "HGNCGENEFAMILY"
      },
      "function": "Protein",
      "id": "090606813841f496585aba8e2b10349e"
    },
    {
      "bel": "path(DOID:\"Alzheimer's disease\")",
      "concept": {
        "name": "Alzheimer's disease",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "bab8638a4ae2b144ee036438e0a858da"
    },
    {
      "bel": "path(DOID:\"Huntington's disease\")",
      "concept": {
        "name": "Huntington's disease",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "a5c9dfe3ed8b0990448319e059ae45cb"
    },
    {
      "bel": "path(DOID:\"Parkinson's disease\")",
      "concept": {
        "name": "Parkinson's disease",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "76019b99765efff85f16f73b8c6f082e"
    },
    {
      "bel": "path(DOID:\"amyotrophic lateral sclerosis\")",
      "concept": {
        "name": "amyotrophic lateral sclerosis",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "c85c0e42ab7cd0643e9447a4444d00ef"
    },
    {
      "bel": "path(DOID:\"multiple sclerosis\")",
      "concept": {
        "name": "multiple sclerosis",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "828e65d53fe5c29b364f79cfd5304f90"
    },
    {
      "bel": "path(DOID:\"muscular atrophy\")",
      "concept": {
        "name": "muscular atrophy",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "9ac138a1ea42125730ade579997a46c1"
    },
    {
      "bel": "path(DOID:neuroblastoma)",
      "concept": {
        "name": "neuroblastoma",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "e59eeb72cf615cf55feec7b6c4a7499b"
    },
    {
      "bel": "path(EFO:stroke)",
      "concept": {
        "name": "stroke",
        "namespace": "EFO"
      },
      "function": "Pathology",
      "id": "1954fbeaa01be628e634f2f5f746a318"
    },
    {
      "bel": "path(HP:\"Caudate atrophy\")",
      "concept": {
        "name": "Caudate atrophy",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "1fd04007b20309f5402e0db777481687"
    },
    {
      "bel": "path(HP:\"Increased reactive oxygen species production\")",
      "concept": {
        "name": "Increased reactive oxygen species production",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "cababfb4fc53a77fa3d9ea44877f17d7"
    },
    {
      "bel": "path(HP:Neurodegeneration)",
      "concept": {
        "name": "Neurodegeneration",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "ff6883c524d877c644e0ba4e8f3323aa"
    },
    {
      "bel": "path(MESH:\"Cytotoxicity, Immunologic\")",
      "concept": {
        "name": "Cytotoxicity, Immunologic",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "29f01312a1c95ba0231e0d65de10c710"
    },
    {
      "bel": "path(MP:0008235)",
      "concept": {
        "name": "0008235",
        "namespace": "MP"
      },
      "function": "Pathology",
      "id": "f8b6e39c8168d559fb86c22c3aeb715a"
    },
    {
      "bel": "r(HGNC:PPARGC1A)",
      "concept": {
        "name": "PPARGC1A",
        "namespace": "HGNC"
      },
      "function": "RNA",
      "id": "f6c6179a699c5d70e41e3ef055b062c6"
    }
  ]
}